
2.09 Delayed Data As of Dec 01 | ![]() Today’s Change | 1.64 Today|||52-Week Range 3.62 | -17.72% Year-to-Date |
Previous close | 2.02 |
Today’s open | 2.03 |
Day’s range | 2.01 - 2.10 |
Volume | 1,748,919 |
Average volume (3 months) | 2,276,979 |
Market cap | $800.3M |
Earnings growth (last year) | +58.14% |
Earnings growth (this year) | +67.22% |
Earnings growth (next 5 years) | +11.54% |
Revenue growth (last year) | +23.47% |
P/E ratio | NM |
Price/Sales | -- |
Price/Book | 0.70 |
Today’s change | Today’s % change | |
---|---|---|
--Abivax SA | 0.00 | 0.00% |
USNAUSANA Health Science... | -0.02 | -0.04% |
---- | ||
---- |
Next reporting date | February 27, 2024 |
EPS forecast (this quarter) | -$0.02 |
Annual revenue (last year) | $91.9M |
Annual profit (last year) | -$168.7M |
Net profit margin | -183.60% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Toronto, Ontario |